Background And Aims: Helicobacter pylori (H. pylori) is a major cause of peptic ulcer disease (PUD) and upper gastrointestinal bleeding. Testing for and eradication of H. pylori reduces the risk of future PUD-related complications including readmission for gastrointestinal bleeding. Our aim was to determine the most cost-effective testing strategy for H. pylori in patients hospitalized with bleeding peptic ulcers.

Methods: We developed a Markov cohort model to compare the following 6 H. pylori testing strategies: no testing, histology, rapid urease test, stool antigen test, urea breath test (UBT), and serology. Histology and rapid urease test require biopsies, while stool antigen test, UBT, and serology do not. We assumed a 17% H. pylori prevalence in patients admitted with bleeding ulcers. Model outcomes included hospitalizations for rebleeds, number needed to treat to avoid another hospitalization, life expectancy, total cost, quality-adjusted life years, and incremental cost-effectiveness ratios.

Results: Compared to no testing, UBT resulted in a gain of 0.02 quality-adjusted life years, total cost savings of $2140 per patient, and 1675 hospitalizations avoided per 10,000 patients per year. Additionally, the number needed to treat to avoid an additional hospitalization over 35 years was 167. UBT was the preferred strategy as it was both less costly and more effective than no testing.

Conclusion: Our findings suggest that UBT is the cost-effective strategy to identify H. pylori in patients admitted with PUD. Noninvasive H. pylori testing at the point of care or during inpatient admission should be considered, as it presents limited risk to patients and offers potential clinical benefits.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849076PMC
http://dx.doi.org/10.1016/j.gastha.2024.100602DOI Listing

Publication Analysis

Top Keywords

pylori patients
12
pylori
9
helicobacter pylori
8
bleeding peptic
8
gastrointestinal bleeding
8
pylori testing
8
histology rapid
8
rapid urease
8
urease test
8
stool antigen
8

Similar Publications

Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori.

BMC Res Notes

March 2025

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Objective: Putative associations between certain bacteria and gastric cancer have been described previously; however, the mechanisms underlying such associations are not thoroughly understood. We aimed to confirm the presence of Fusobacterium nucleatum in the biopsy samples of patients with gastroduodenal diseases, including gastric cancer, with concomitant or without Helicobacter pylori infection.

Results: Three hundred patients with gastroduodenal disorders, including gastritis, duodenal ulcer, or gastric cancer, were included.

View Article and Find Full Text PDF

Objectives: This study aimed to use the real-time RT-PCR method to detect the gene expression cytokines IL-10, TNFα, IFN-γ, and TGF-β in the serum of Alzheimer's patients.

Methods: This study was conducted on 100 serum samples of Alzheimer's patients. DNA extraction was performed on the samples with the Cinnaclone kit and PCR techniques were used to detect the presence of Helicobacter pylori, Chlamydia trachomatis, and Varicella zoster virus.

View Article and Find Full Text PDF

Unveiling the therapeutic effects of traditional Chinese patent medicines: A network meta-analysis on chronic atrophic gastritis.

Medicine (Baltimore)

March 2025

Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan Province, China.

Background: The study aimed to conduct a network meta-analysis of randomized controlled trials (RCTs) to examine the effectiveness and safety of traditional Chinese patent medicine (TCPM), either used alone or combined with conventional treatment (CT) of chemical drugs, for treating chronic atrophic gastritis (CAG).

Methods: We searched the literature from database creation to December 2023; our primary endpoint was clinical response rate. Secondary outcome measures were the inhibition rate of Helicobacter pylori and clinical symptom score, including pain and noisy scores for the stomach, score for belch and acid reflux, score for the bitter taste and the dry throat, and safety according to total adverse events.

View Article and Find Full Text PDF

Objective: To investigate immune cell crisis and excess histopathological features during the development and progression of infection in the gastric mucosa.

Methods: One thousand two hundred and seventy-six cases of infection were examined by endoscopic biopsy and endoscopic submucosal dissection (ESD) resection. The relationship between epithelial cells and immune cells and the pathological features of immune cell dysfunction and excess tissue were observed.

View Article and Find Full Text PDF

Mind the gut: Navigating the complex landscape of gastroprotection in neurosurgical patients.

World J Gastroenterol

February 2025

Department of Neurosurgery, University of Flordia, Gainesville, FL 32608, United States.

Neurosurgical patients, including those with severe traumatic brain injury, spinal cord injury, stroke, or raised intracranial pressure, are at heightened risk for stress ulcers and aspiration pneumonitis, leading to significant morbidity and mortality. These patients are typically managed through both pharmacological interventions [, proton pump inhibitors (PPIs), histamine 2 (H2) antagonists, sucralfate] and non-pharmacological measures (, nasogastric decompression, patient positioning) to mitigate adverse outcomes. The pathogenesis of stress ulcers in neurosurgical patients is multifactorial, but the routine use of stress ulcer prophylaxis remains controversial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!